Psylo is a biotech company developing medications inspired by psychedelics found in nature. Our goal is to produce next-generation neuropsychiatric therapeutics which are accessible to a broader patient population. Psylo is based at the University of New South Wales, and was named a Top 100 Innovator by The Australian Business Review.